Actuate Therapeutics receives Nasdaq delisting warning over minimum bid price.
SEC EDGAR, 2026-10-30: 8-K (Item 3.01) — "notice of delisting"
Actuate Therapeutics receives Nasdaq delisting warning over minimum bid price.
Company: Actuate Therapeutics, Inc. (ACTU) Filed: October 30, 2026, 8-K (Item 3.01) Phrase: "notice of delisting" — "On October 28, 2026, Actuate Therapeutics, Inc. (the “Company”) received a written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock (the “Common Stock”) had closed below the $1.00 per share minimum bid price requirement for continued inclusion on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”)." What the filing says: Actuate Therapeutics received a Nasdaq deficiency notice because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The notice does not immediately affect its listing. The company has 180 calendar days, or until April 26, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for at least 10 consecutive business days. If it fails to do so, it may apply to transfer to the Nasdaq Capital Market for a second 180-day compliance period, provided it meets other listing standards. This notice is separate from a prior July 15, 2026 notice regarding non-compliance with Nasdaq's minimum market value of listed securities (MVLS) requirement, which has a compliance deadline of January 11, 2027. Two ways it goes: A. The company's closing bid price reaches at least $1.00 for 10 consecutive business days and it regains Nasdaq compliance. B. The stock fails to meet the minimum bid price requirement and is delisted from the exchange. Next date: January 11, 2027 (deadline to regain compliance with the separate MVLS requirement) and April 26, 2027 (deadline to regain compliance with the minimum bid price requirement). Watch: SEC filings or Nasdaq announcements confirming compliance or a delisting determination. Tags: delisting notice